IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 152 filers reported holding IMMUNOVANT INC in Q2 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $704 | -6.6% | 37,135 | -23.6% | 0.01% | 0.0% |
Q1 2023 | $754 | -99.4% | 48,595 | +113.4% | 0.01% | +200.0% |
Q3 2022 | $127,000 | -89.6% | 22,776 | -92.7% | 0.00% | -86.7% |
Q2 2022 | $1,222,000 | -25.6% | 313,356 | +5.1% | 0.02% | -28.6% |
Q1 2022 | $1,642,000 | -4.1% | 298,070 | +48.3% | 0.02% | +16.7% |
Q4 2021 | $1,713,000 | +47.9% | 201,044 | +50.9% | 0.02% | +12.5% |
Q3 2021 | $1,158,000 | -59.8% | 133,200 | -51.2% | 0.02% | -50.0% |
Q2 2021 | $2,882,000 | +732.9% | 272,717 | +1151.0% | 0.03% | +433.3% |
Q4 2019 | $346,000 | – | 21,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpine Global Management, LLC | 1,439,544 | $22,327,327 | 8.67% |
Logos Global Management LP | 2,500,000 | $38,775,000 | 5.55% |
Deep Track Capital, LP | 7,432,717 | $115,281,441 | 4.74% |
COMMODORE CAPITAL LP | 1,440,999 | $22,349,894 | 3.40% |
Ikarian Capital, LLC | 774,398 | $12,010,913 | 2.72% |
COWEN AND COMPANY, LLC | 1,250,000 | $19,387,500 | 2.28% |
HighVista Strategies LLC | 163,799 | $2,540,522 | 2.07% |
TCG Crossover Management, LLC | 654,853 | $10,156,770 | 1.98% |
BVF INC/IL | 2,561,000 | $39,721,110 | 1.45% |
Redmile Group, LLC | 1,317,031 | $20,427,151 | 0.89% |